Skip to main content

Major Depressive Disorder

SAN DIEGO—Charles F. Zorumski, MD, presented an update on gamma-aminobutyric acid (GABA), a complex neurotransmitter he has been studying for more 30 years, at the Psych Congress 2019 Practical Psychopharmacology Pre-Conference.
Sertraline eased anxiety symptoms and improved self-reported mental health within 6 weeks in primary care patients with symptoms of depression, according to a study published online in The Lancet Psychiatry.
The strongest evidence for the use of nutritional supplements for mental health supports omega-3 as an add-on treatment for major depression, according to a new meta-review.
Exercise is effective for both preventing and treating depression, yet the intervention does not receive the acknowledgement it warrants in clinical practice, reports a new review and meta-analysis published in Current Sports Medicine Reports.
Adding fluoxetine to cognitive behavioral therapy (CBT) did not reduce depressive symptoms in young people with moderate-to-severe major depressive disorder, researchers say.
Psychedelics researcher Robin Carhart-Harris, PhD, who delivered the opening session at Psych Congress 2018, spoke about the compounds at the World Economic Forum Annual Meeting in Davos, Switzerland.
Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.
Listen as Psych Congress Steering Committee member Charles Raison, MD, discusses a book he coauthored, The New Mind-Body Science of Depression, with David Van Nuys, PhD, on Shrink Rap Radio.
Listen to Charles Raison, MD, discuss his JAMA Psychiatry study examining the relationship between inflammation and depression.
Back to Top